MARC details
000 -LEADER |
fixed length control field |
02627nam a22002657a 4500 |
001 - CONTROL NUMBER |
control field |
20240819092803.0 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
20240819092803.0 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240819093242.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
240819b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
978-3-319-40234-5 |
|
International Standard Book Number |
978-3-319-40236-9 |
040 ## - CATALOGING SOURCE |
Transcribing agency |
ddc |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
100 ## - MAIN ENTRY--PERSONAL NAME |
Fuller form of name |
Chiara Lestuzzi |
245 ## - TITLE STATEMENT |
Title |
Manual of Cardio-oncology |
Remainder of title |
Cardiovascular Care in the Cancer Patient |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Aviano (PN), Italy : |
Name of publisher, distributor, etc. |
Springer International Publishing Switzerland : |
Date of publication, distribution, etc. |
2017 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
472 Pages |
Other physical details |
Includes References and Index |
490 ## - SERIES STATEMENT |
Series statement |
DOI 10.1007/978-3-319-40236-9 |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This concise and handy manual provides straightforward, up-to-date guidance for cardiologists and other practitioners on the management of cancer patients with cardiac problems, whether they be due to the cancer itself or to antineoplastic treatment. Detailed attention is devoted to the various forms of cardiotoxicity associated with chemotherapy and radiotherapy. The drugs commonly responsible for each toxicity are identified and clear advice is offered on monitoring techniques and treatment approaches. In addition, the issue of cardiotoxicity due to cancer treatment in particular patient groups – children, the elderly, and those with pre-existing cardiac disease – is addressed separately, with guidance on when and how antineoplastic (and/or cardiological) treatments should be modified. Further sections describe the correct responses to cardiac problems secondary to the cancer itself, including thromboembolic disorders and electrolyte imbalances, and the diagnosis, treatment, and follow-up of cardiac tumors. A closing section considers how to improve cooperation between oncologists, cardiologists, and general practitioners to ensure that cancer patients’ cardiovascular needs are met in a multidisciplinary approach. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
General subdivision |
Cardiology, Family medicine, Geriatrics, Medical / Cardiology, Medical / Clinical Medicine, Medical / Family & General Practice, Medical / Geriatrics, Medical / Oncology / General, Medical / Pain Management, Medical / Pharmacology, Medical / Practice Management & Reimbursement, Oncology, Pain medicine, Therapeutics, Medical / Diseases, Medical / Internal Medicine, Medical / Physical Medicine & Rehabilitation, Cancer -- Complications, Cardiovascular system -- Diseases, Chemotherapy, General practice (Medicine), Medicine, Medicine and Public Health |
700 ## - ADDED ENTRY--PERSONAL NAME |
Fuller form of name |
Stefano Oliva |
|
Fuller form of name |
Francesco Ferraù |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="DOI 10.1007/978-3-319-40236-9 ">DOI 10.1007/978-3-319-40236-9 </a> |
Link text |
DOI 10.1007/978-3-319-40236-9 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
ddc |
Koha item type |
E-BOOKS |
Suppress in OPAC |
|